The global breast imaging market is projected to witness substantial growth, reaching an estimated valuation of USD 9,263.4 million by 2034. According to industry projections, sales are expected to rise at a steady compound annual growth rate (CAGR) of 6.5% from 2024 to 2034. In 2024 alone, the market is estimated to be worth USD 4,934.9 million, reflecting a continued upward trajectory from USD 4,633.7 million in 2023.
Breast imaging devices play a crucial role in the early detection and diagnosis of breast cancer. These advanced medical technologies include mammography machines, which utilize X-rays to identify abnormalities in breast tissue, and ultrasound scanners that employ sound waves to examine lumps or cysts. Their ability to detect disease at an early stage significantly improves patient outcomes, making them an integral part of breast cancer management worldwide.
The increasing adoption of breast imaging solutions in hospitals and diagnostic centers is a key driver of market expansion. These technologies provide a non-invasive and accurate approach to breast health monitoring, contributing to higher survival rates and enhanced patient care. The growing awareness of breast cancer and advancements in imaging technology further fuel the demand for these devices.
Request a Sample Copy Now : – https://www.futuremarketinsights.com/report-sample#5245502d47422d3134373936
Key Takeaways
- The breast imaging market is expected to grow at a CAGR of 6.5% from 2024 to 2034.
- Market value projected to reach USD 9,263.4 million by 2034, up from USD 4,934.9 million in 2024.
- Breast imaging devices, including mammography and ultrasound scanners, play a crucial role in early disease detection.
- Rising hospital adoption and technological advancements are driving market growth.
Key Insights
- Technology and Equipment: Breast imaging encompasses advanced technologies including mammography machines and ultrasound scanners, which are essential for the early detection and diagnosis of breast cancer. These devices provide detailed imaging that aids in identifying abnormalities in breast tissue.
- Impact on Survival Rates: Regular use of breast imaging technologies has significantly improved early detection rates, leading to increased survival rates and better overall management of breast health.
Market Drivers
- Rising Incidence of Breast Cancer:
- The increasing prevalence of breast cancer globally drives demand for effective screening and diagnostic tools, thereby boosting the breast imaging market.
- Growing Awareness for Early Detection:
- There is heightened awareness among women regarding the importance of regular breast screenings for early detection of cancer, which contributes to increased utilization of imaging services.
- Technological Advancements:
- Continuous innovations in imaging technology enhance diagnostic accuracy and patient outcomes, making these tools more effective and appealing to healthcare providers.
- Government Initiatives and Funding:
- Increased government support for breast cancer awareness campaigns and screening programs encourages more women to seek preventive care, further driving market growth.
- Urbanization and Accessibility:
- As urban populations grow, the demand for accessible healthcare services increases, prompting healthcare facilities to invest in advanced breast imaging technologies.
Key Players of Breast Imaging Industry
- HOLOGIC, INC.
- GE HEALTHCARE
- SIEMENS HEALTHCARE
- KONINKLIJKE PHILIPS N.V.
- FUJIFILM HOLDINGS CORPORATION
- CANON INC.
Key Segments of Breast Imaging Industry
By Technology:
In terms of Technology, the industry is divided into ionizing breast imaging (mammography, positron emission tomography-computed tomography (PET-CT), molecular breast imaging (MBI), positron emission mammography (PEM), and cone-beam computed tomography (CBCT)) and non-ionizing breast imaging (breast ultrasound, breast MRI, automated whole-breast ultrasound (AWBU), breast thermography, electric impedance tomography and optical imaging)
By End User:
In terms of end user, the industry is segregated into hospitals & clinics, diagnostic imaging centers, breast care centers and other end users
By Region:
Key countries of North America, Latin America, Europe, East Asia, South Asia, Middle East and Africa (MEA), and Oceania have been covered in the report.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
